CD36 and breast carcinoma: Despite consistent correlation in expression between CD36, LPL, PDK4, and FABP4 in all breast cancer subtypes (data not shown), the only subtype that displayed poorer survival was CL-TNBC (p = 0.0119; HR = 1.92; Fig. 5i, j and Supplementary Fig. S5k–p).